MAGNI, FULVIO
 Distribuzione geografica
Continente #
NA - Nord America 20.969
EU - Europa 11.503
AS - Asia 4.991
SA - Sud America 235
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 15
Totale 37.760
Nazione #
US - Stati Uniti d'America 20.480
IT - Italia 2.755
DE - Germania 1.961
SG - Singapore 1.950
CN - Cina 1.643
SE - Svezia 1.614
IE - Irlanda 1.561
UA - Ucraina 824
RU - Federazione Russa 792
HK - Hong Kong 698
GB - Regno Unito 576
CA - Canada 463
AT - Austria 358
FI - Finlandia 296
FR - Francia 198
BR - Brasile 194
VN - Vietnam 185
IN - India 133
NL - Olanda 127
DK - Danimarca 122
ID - Indonesia 100
BE - Belgio 87
TR - Turchia 85
JP - Giappone 43
PL - Polonia 32
IR - Iran 29
CZ - Repubblica Ceca 28
ES - Italia 27
RO - Romania 23
BG - Bulgaria 20
EU - Europa 20
CH - Svizzera 19
GR - Grecia 17
KR - Corea 16
MX - Messico 14
TW - Taiwan 14
NO - Norvegia 13
IL - Israele 12
LT - Lituania 12
AU - Australia 10
EC - Ecuador 10
PH - Filippine 10
UZ - Uzbekistan 9
AZ - Azerbaigian 8
MY - Malesia 8
PT - Portogallo 8
AR - Argentina 6
BD - Bangladesh 6
CL - Cile 6
LV - Lettonia 6
MA - Marocco 6
PK - Pakistan 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
PA - Panama 5
PE - Perù 5
SK - Slovacchia (Repubblica Slovacca) 5
VE - Venezuela 5
HU - Ungheria 4
MT - Malta 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CO - Colombia 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
AL - Albania 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
HR - Croazia 2
IM - Isola di Man 2
JO - Giordania 2
KZ - Kazakistan 2
MU - Mauritius 2
PY - Paraguay 2
RS - Serbia 2
SC - Seychelles 2
SI - Slovenia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BT - Bhutan 1
CI - Costa d'Avorio 1
EE - Estonia 1
JM - Giamaica 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
ML - Mali 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
TG - Togo 1
TJ - Tagikistan 1
Totale 37.757
Città #
Ann Arbor 4.346
Woodbridge 1.851
Fairfield 1.644
Chandler 1.520
Dublin 1.517
Singapore 1.269
Houston 1.220
Frankfurt am Main 1.095
Ashburn 1.050
Milan 1.020
Wilmington 1.013
Jacksonville 871
Dearborn 742
Hong Kong 683
Seattle 677
Santa Clara 604
New York 586
Cambridge 549
Princeton 456
Vienna 322
Shanghai 300
Nanjing 295
Altamura 181
Lawrence 175
Beijing 158
Lachine 143
Montréal 142
Helsinki 133
Dong Ket 127
Munich 116
Nanchang 115
Council Bluffs 105
Fremont 100
Jakarta 93
Guangzhou 90
Los Angeles 88
Brussels 79
Andover 77
San Diego 76
Toronto 73
Ottawa 71
Shenyang 70
Hebei 66
London 60
Boardman 59
Tianjin 50
Changsha 49
Lissone 45
Jiaxing 44
Nuremberg 44
Rome 44
Jinan 41
Chicago 40
Falls Church 38
Huizen 37
Zhengzhou 37
Florence 36
Pune 35
Mountain View 34
Norwalk 34
Nürnberg 32
Caronno Pertusella 31
Ningbo 30
Kunming 28
Washington 28
Monza 27
Brescia 26
Auburn Hills 25
Cinisello Balsamo 24
Edmonton 23
Dallas 21
Brno 20
Pavia 20
Romola 20
São Paulo 20
Turin 20
Como 19
San Mateo 19
Sesto San Giovanni 19
Detroit 18
Hangzhou 18
Kiev 18
Melzo 18
Bonndorf 17
Hefei 17
Padova 17
Plovdiv 17
Taizhou 17
Kilburn 16
Napoli 16
Sacramento 16
University Park 16
Carate Brianza 15
Terni 15
Kocaeli 14
Madison 14
Ripalta Cremasca 14
Naples 13
Bergamo 12
San Giuliano Milanese 12
Totale 27.417
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 437
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 378
Comparative membrane proteomics: A technical advancement in the search of renal cell carcinoma biomarkers 368
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 353
Respiratory metabolism and calorie restriction relieve persistent endoplasmic reticulum stress induced by calcium shortage in yeast 348
Differential protein profiling of renal cell carcinoma urinary exosomes 332
Cholinergic ligand [C-11]MP4A: Improved 4-acetoxypiperidine precursor synthesis via LC-APCI/MS characterisation and improved radioligand HPLC purification 327
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 320
Urinary exosomes and diabetic nephropathy: a proteomic approach 307
MALDI imaging in Fabry nephropathy: a multicenter study 306
Urinary proteomics for the study of genetic kidney diseases 289
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 286
Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges 282
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 275
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 275
The PAF-acether receptor antagonist BN-52021 inhibits mediator release during guinea-pig active lung anaphylaxis 274
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 274
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 274
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 273
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 272
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 267
Serum biomarkers of Renal Cell Carcinoma assessed using a protein profiling approach based on ClinProt technique 266
3D bioprinted colorectal cancer models based on hyaluronic acid and signalling glycans 264
The proteomic landscape of renal tumors 258
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 258
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 256
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 246
The putative role of MALDI-MSI in the study of Membranous Nephropathy 243
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 243
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 242
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 242
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 239
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 239
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 237
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 234
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 234
Robust conclusions in mass spectrometry analysis 233
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 232
Mutual Information Optimization for Mass Spectra Data Alignment 231
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing 225
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 224
Proteomics for the diagnosis of thyroid lesions: Preliminary report 222
Urinary extracellular vesicles and salt-losing tubulopathies: A proteomic approach 222
Expression of heat shock protein 27 in human renal cell carcinoma 220
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy 219
Improved synthesis and radiolabeling of [C-11]MP4A, a suitable ligand for the investigation of the cholinergic system using PET 218
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 218
Proteomics for the study of new biomarkers in Fabry disease: State of the art 211
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 210
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors 209
Tumor size, stage and grade alterations of urinary peptidome in RCC 208
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3 207
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 207
Proteome analysis in thyroid pathology 202
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 202
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 202
A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: Application to RCC urinary exosomes 200
Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery 199
Analysis of correlation structures in renal cell carcinoma patient data 195
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples 193
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 191
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt 189
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma 189
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 188
1H NMR analysis of isocyclosporin A prepared in organic solvent and in aqueous solution 183
Radiosynthesis of [123I]βCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain 183
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 182
Characterization of heat shock protein 27 phosphorylation sites in renal cell carcinoma 182
Imaging mass spectrometry: a new tool for kidney disease investigations 180
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 179
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 178
Diabetes-induced alteration of HMGCoA reductase forms in rat livers 176
Enzymatic synthesis of [methyl-2H3] creatinine 173
Proteomic knowledge of human aquaporins 172
HNE-Abeta adducts evaluated in vitro and in washed platelets by HPLC-ESI-MS 172
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE 171
MALDI-MSI analysis of cytological smears: The study of thyroid cancer 171
Differential expression of AQP1 in microdomain-enriched membranes of Renal Cell Carcinoma 170
Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues 170
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 169
A Mutual Information Approach to Data Integration for Alzheimer’s Disease Patients 169
Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach 169
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 169
1st National Congress of the Italian Proteome Society 167
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand 167
A molecular imaging approach to individuate tumour infiltrating lymphocytes 167
Intraluminal proteome and peptidome of human urinary extracellular vesicles 166
The urinary proteome and peptidome of renal cell carcinoma patients: A comparison of different techniques 166
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data 165
Sensitive GC-MS method for the determination of specific-activity of 16a[18F]Fluoro-estra-1,3,5(10)-triene-3,17b-diol 164
Mutations of the CK2 phosphorylation site of Sic1 affect cell size and S-Cdk kinase activity in Saccharomyces cerevisiae 163
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 162
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 160
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 158
Synthesis and in vivo evaluation of [C-11]CGP62349, a new GABA(B) receptor antagonist 158
Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative 158
Determination of plasma [6,6-2H2]glucose enrichment by a simple and accurate gas chromatographic-mass spectrometric method 157
Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis 157
Comparative proteomics of membrane microdomains from renal cell carcinoma and adiacent normal kidney 156
Applying Random Graphs for Proteomic Data Analysis of RCC Patients 156
Totale 22.149
Categoria #
all - tutte 139.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020884 0 0 0 0 0 0 0 0 0 346 390 148
2020/20215.044 282 242 520 592 447 406 535 462 387 468 260 443
2021/20223.272 261 295 307 415 200 267 119 192 156 244 282 534
2022/20236.033 670 1.860 485 603 352 860 72 375 380 62 183 131
2023/20244.723 138 155 192 320 515 1.359 988 125 295 76 121 439
2024/20255.899 470 925 598 458 900 393 568 461 1.107 19 0 0
Totale 39.059